Defender Capital LLC. Has $3.77 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Defender Capital LLC. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1,386.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,470 shares of the medical equipment provider’s stock after purchasing an additional 8,833 shares during the quarter. Intuitive Surgical comprises 1.2% of Defender Capital LLC.’s holdings, making the stock its 15th largest holding. Defender Capital LLC.’s holdings in Intuitive Surgical were worth $3,766,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Main Street Group LTD bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at $30,000. Laurel Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at $31,000. Vermillion Wealth Management Inc. boosted its stake in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares in the last quarter. Turning Point Benefit Group Inc. boosted its stake in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in Intuitive Surgical in the fourth quarter worth $34,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have weighed in on ISRG shares. Barclays set a $651.00 price target on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Deutsche Bank Aktiengesellschaft decreased their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research report on Tuesday, June 2nd. Finally, Evercore set a $430.00 price target on Intuitive Surgical in a report on Monday, July 6th. Twenty analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $509.02.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $393.38 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The firm has a 50-day moving average price of $392.49 and a two-hundred day moving average price of $444.21. The firm has a market cap of $138.97 billion, a price-to-earnings ratio of 45.06, a price-to-earnings-growth ratio of 2.74 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.81 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 6,634 shares of company stock worth $2,769,615. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.